Krystal Biotech, Inc. (KRYS)

NMS – Real Time Price. Currency in USD

331.07

+4.02 (1.23%)

Market open: Aug 12, 2026, 11:38 AM EDT

325.00

-2.05 (-0.63%)

Previous after-hours: Aug 11, 2026, 7:56 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

389M

291M

51M

Cost of goods sold

-29M

-27M

-8M

-4M

Gross Profit

360M

264M

43M

-4M

Operating expenses (excl. COGS)

-199M

-161M

-140M

-116M

Operating Income

161M

103M

-97M

-120M

Non-operating income, total

28M

-8M

110M

-20M

Pretax income

189M

95M

13M

-140M

Equity in earnings

Taxes

15M

-6M

-2M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

205M

89M

11M

-140M

Discontinued operations

Net income

205M

89M

11M

-140M

Dilution adjustment

Preferred dividends

Krystal Biotech, Inc. (KRYS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Krystal Biotech, Inc. (KRYS)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Krystal Biotech, Inc. (KRYS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Krystal Biotech, Inc. (KRYS)

Income Statement (Annual)

Income Statement (Annual)